Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$4,030,085
+$878,034 QoQ
Shares Held
3,360
-2.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
4.46%
of 13F equity value
Holder Rank
#1,878
of 4,605 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Etesian Wealth Advisors, Inc. holds $8,238,349 across 4 Drug Manufacturers - General names. LLY ranks #1 (48.9% of the industry book) .
All Filings in LLY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,030,085 | 3,360 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $3,152,051 | 3,427 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $3,824,786 | 3,559 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,744,511 | 3,597 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $2,870,229 | 3,682 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $3,044,304 | 3,686 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $3,011,572 | 3,901 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $3,541,102 | 3,997 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $3,669,505 | 4,053 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $3,237,091 | 4,161 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $2,504,807 | 4,297 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $2,432,661 | 4,529 | Shares | Sole | 2024-01-16 | |
| 2023-06-30 | $2,348,651 | 5,008 | Shares | Sole | 2024-01-16 | |
| 2023-03-31 | $1,751,785 | 5,101 | Shares | Sole | 2024-01-16 | |
| 2022-12-31 | $1,893,222 | 5,175 | Shares | Sole | 2024-01-16 | |
| No filing history on record for this holder in this stock. | ||||||